On September 26, 2011, the Company issued a press release announcing the receipt of a letter from the FDA stating that corrective actions proposed by the business, once fully implemented, should address the observations created by the FDA investigators adequately. The letter also indicated that the Organization's corrective activities would be verified by the FDA in another facility inspection. July 11 From, 2013 through July 18, 2013, the FDA carried out a general inspection of the company's Burlington service, operations and quality systems, including a systematic overview of corrective actions related to the 2011 Form 483.Both these units of mutant mice had been treated with the enzyme adenosine deaminase enzymes to lessen adenosine levels. After 8 weeks, they found that this enzyme significantly lowered adenosine levels in the penises of both combined groups of test mice. Reduction of adenosine by these enzymes successfully avoided and corrected penile fibrosis in both models of mice. ‘Because of our study, we’ve revealed that elevated adenosine signaling plays a part in the pathogenesis of the progression of priapism to penile fibrosis,’ said Yang Xia, a scientist mixed up in study from the University of Texas-Houston Medical School’s Division of Biochemistry and Molecular Biology.